Phase II Study of Capecitabine in Combination With Vinorelbine and Trastuzumab for the First- or Second-LineTreatment of HER2+ Metastatic Breast Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Capecitabine; Trastuzumab; Vinorelbine
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 06 Mar 2017 Biomarkers information updated
- 18 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 18 Jun 2012 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.